A pilot study to assess the influence of drug transporters on brain and organ distribution of erlotinib in humans

Trial Profile

A pilot study to assess the influence of drug transporters on brain and organ distribution of erlotinib in humans

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Erlotinib (Primary) ; Tariquidar
  • Indications Bladder cancer; Brain metastases; Ependymoma; Glioblastoma; Gynaecological cancer; Head and neck cancer; Myelodysplastic syndromes; Non-small cell lung cancer; Pancreatic cancer; Squamous cell cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 15 Mar 2017 Planned number of patients changed from 40 to 77.
    • 12 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top